Rapacuronium administration to patients receiving phenytoin or carbamazepine

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Anticonvulsant medications, specifically phenytoin and carbamazepine, can alter patient responses to neuromuscular blocking agents.
• Understanding these interactions is crucial for safe and effective anesthetic management.

Observation:

• This study investigated the effects of rapacuronium bromide, a neuromuscular blocking agent, in two adult patients receiving anticonvulsants.
• One patient received phenytoin, and the other received carbamazepine.

Findings:

• Both patients exhibited delayed onset of maximum neuromuscular blockade with rapacuronium bromide.
• Complete blockade was not achieved in the patient on phenytoin.
• Neuromuscular recovery was rapid, with shortened clinical duration and recovery index observed in both patients.

Implications:

• The findings suggest that phenytoin and carbamazepine may shorten the duration of action and accelerate recovery from rapacuronium bromide.
• These results align with previous observations for other aminosteroid neuromuscular blocking agents.
• Anesthesiologists should consider potential anticonvulsant-induced resistance and altered recovery profiles when using rapacuronium bromide.